Gilead Sciences Inc (GILD) stock news · rev $29.44B
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
This GILD news page leads with what Gilead Sciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for GILD yet. We will not pad this page with generic market recap.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the GILD stock page; for the tape open the quote page.
GILD stock news FAQ
What are GILD's latest revenue and net income?
Latest cached Gilead Sciences Inc (GILD) revenue for Dec 31, 2025 was $29.44B. Net income was $8.51B. Statements: https://lician.com/financials/gild
How did GILD revenue change from the prior cached period?
Cached Gilead Sciences Inc (GILD) revenue was up 2.4% from $28.75B (Dec 31, 2024) to $29.44B (Dec 31, 2025). Statements: https://lician.com/financials/gild
What is GILD's market cap?
Gilead Sciences Inc (GILD) market cap is $160.15B on the latest cached fundamentals snapshot.
What kind of company is GILD?
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Where is GILD stock news listed?
Cached stock news for Gilead Sciences Inc (GILD) is listed at https://lician.com/news/gild. Filings: https://lician.com/sec/gild
Not investment advice.